Fust Matthew K (CIK 0001397266)

Latest company ownership

Shares held
18,188
Last filed at
Jun 12, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
10,787
Last filed at
May 19, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4
Shares held
10,000
Last filed at
Sep 30, 2025
Confidence Score
42.5
2025Q4
Confidence Score History
2019Q4 2025Q4
MGNX - MACROGENICS INC
Role: Director
Shares held
10,000
Last filed at
May 20, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q1 2025Q4
Shares held
7,844
Last filed at
Oct 18, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2024Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 26, 2025 Sep 30, 2025 Crinetics Pharmaceuticals, Inc. Director Sell 7.5 -16,000 -41.20% ✓ $716K
Oct 17, 2024 Oct 18, 2024 Neumora Therapeutics, Inc. Director Sell 7.5 -21,788 -35.15% ✓ $371K
Mar 20, 2024 Mar 22, 2024 Crinetics Pharmaceuticals, Inc. Director Sell 5.0 -60,000 -44.73% ✓ $2.6M
Mar 7, 2024 Mar 11, 2024 Ultragenyx Pharmaceutical Inc. Director Sell 20.0 -12,195 -45.07% ✗ $620.4K
Jun 7, 2023 Jun 9, 2023 Ultragenyx Pharmaceutical Inc. Director Sell 82.5 +560 2.11% ✗ $171K
Jul 13, 2022 Jul 15, 2022 Crinetics Pharmaceuticals, Inc. Director Sell 10.0 -5,700 -31.26% ✓ $119.5K
Nov 4, 2021 Nov 5, 2021 Atara Biotherapeutics, Inc. Director Sell 7.5 -13,354 -29.77% ✓ $260.4K
Nov 1, 2021 Nov 3, 2021 Crinetics Pharmaceuticals, Inc. Director Sell 10.0 -8,954 -41.67% ✓ $228.3K
Sep 8, 2021 Sep 9, 2021 Crinetics Pharmaceuticals, Inc. Director Sell 10.0 -6,046 -32.54% ✓ $154.2K
Jul 26, 2021 Jul 27, 2021 Crinetics Pharmaceuticals, Inc. Director Sell 10.0 -5,000 -28.51% ✓ $98K
Jul 19, 2021 Jul 20, 2021 Crinetics Pharmaceuticals, Inc. Director Sell 10.0 -5,000 -28.51% ✓ $97.5K
Jul 12, 2021 Jul 13, 2021 Crinetics Pharmaceuticals, Inc. Director Sell 10.0 -5,000 -28.51% ✓ $103.6K
Jul 6, 2020 Jul 8, 2020 Ultragenyx Pharmaceutical Inc. Director Sell 7.5 -6,181 -31.33% ✓ $556.3K
Jul 1, 2020 Jul 6, 2020 Ultragenyx Pharmaceutical Inc. Director Sell 7.5 -5,000 -26.95% ✓ $425K
May 18, 2020 May 19, 2020 Ultragenyx Pharmaceutical Inc. Director Sell 25.0 -1,875 -14.56% ✓ $140.6K
Apr 22, 2020 Apr 24, 2020 Ultragenyx Pharmaceutical Inc. Director Sell 25.0 -1,875 -12.71% ✓ $121.9K
Dec 16, 2019 Dec 18, 2019 Crinetics Pharmaceuticals, Inc. Director Sell 15.0 -3,500 -21.83% ✓ $78.8K
Feb 6, 2019 Feb 8, 2019 MACROGENICS INC Director Sell 10.0 -6,924 -93.27% ✓ $203.4K
May 30, 2018 May 30, 2018 Ultragenyx Pharmaceutical Inc. Director Sell 7.5 -6,319 -41.93% ✓ $455K
May 14, 2018 May 16, 2018 Atara Biotherapeutics, Inc. Director Sell 20.0 -12,286 -38.27% ✗ $535.3K